Preterm Birth and PROM Testing Market Size, Industry Trends, Share, Growth & Forecast Report 2024-2032

IMARC Group has recently released a new research study titled "Preterm Birth and PROM Testing Market Report by Test Type (Pelvic Exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitrazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), and Others), Application (PROM, Preterm Labor, Chorioamnionitis), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2024-2032", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

The global preterm birth and PROM testing market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032.

Request to Get the Sample Report: https://www.imarcgroup.com/preterm-birth-prom-testing-market/requestsample

Factors Affecting the Growth of the Preterm Birth and PROM Testing Industry:

• Increasing Rates of Preterm Births:

The rising global incidence of preterm births is a critical driver for the preterm birth and PROM testing market. Preterm births, defined as births occurring before 37 weeks of gestation, pose significant health risks to infants, including respiratory issues, neurological impairments, and long-term developmental delays. Factors such as maternal age, lifestyle changes, multiple pregnancies due to assisted reproductive technologies, and chronic health conditions like diabetes and hypertension contribute to the increasing rates.

This upward trend necessitates more reliable and early diagnostic tools to manage and mitigate risks associated with premature deliveries. Effective screening for preterm labor and PROM can significantly reduce complications by enabling timely medical interventions, thus improving neonatal outcomes.  

• Advancements in Testing Technologies:

Technological advancements in preterm birth and PROM testing are revolutionizing the market by improving diagnostic accuracy and patient outcomes. New developments in point-of-care testing (POCT) devices and non-invasive testing methods allow for quicker and more precise detection of preterm labor and membrane rupture. These technologies utilize biomarkers, genetic profiling, and other advanced diagnostic tools to predict preterm birth risks with higher sensitivity and specificity than traditional methods.

Innovations such as rapid bedside tests and automated diagnostic platforms enable healthcare providers to make timely decisions, reducing the need for invasive procedures and hospital admissions. As these technologies become more accessible and affordable, they are increasingly adopted by healthcare facilities worldwide.  

• Awareness Campaigns by Health Organizations:

Awareness campaigns led by health organizations significantly impact the preterm birth and PROM testing market by educating the public and healthcare professionals about the importance of early detection and intervention. These campaigns, often run by government bodies, non-profits, and international health organizations, focus on increasing awareness of the risks associated with preterm births and the benefits of regular prenatal testing.

Through workshops, seminars, social media outreach, and partnerships with healthcare providers, these initiatives help disseminate information about the latest testing methods and encourage their adoption. As awareness grows, more pregnant women undergo routine screenings, leading to early identification and management of potential preterm birth risks.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=8617&flag=C

Preterm Birth and PROM Testing Market Report Segmentation:

By Test Type:

• Pelvic Exam
• Ultrasound
• Biochemical Markers
  • Interleukin (IL)-6
  • C-Reactive Protein (CRP)
  • IL-1, IL-2, IL-8, TNF-a
  • Corticotropin-Releasing Hormone (CRH)
  • Alpha-fetoprotein (AFP)
• Uterine Monitoring
• Nitrazine Test
• Ferning Test
• Pooling
• PAMG-1 Immunoassay
• IGFBP Test
• Fetal Fibronectin (fFN)
• Others  

Ultrasound represented the largest segment because it is a widely accessible, non-invasive, and reliable method for assessing fetal development and detecting potential complications early in pregnancy.

By Application:

• PROM
• Preterm Labor
• Chorioamnionitis

Preterm labor represented the largest segment due to the high incidence of preterm births and the critical need for timely diagnosis and intervention to prevent adverse outcomes.

By End User:

• Hospitals
• Diagnostic Laboratories
• Others
  
  

Hospitals represented the largest segment as they are the primary centers for prenatal care and possess the necessary infrastructure and expertise to conduct comprehensive testing and manage high-risk pregnancies.

 Regional Insights:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America was the largest market because of its advanced healthcare system, high awareness about prenatal care, and significant investments in maternal and fetal health technologies.

Global Preterm Birth And PROM Testing Market Trends:

The global preterm birth and PROM (premature rupture of membranes) testing market is expanding due to the increasing rates of preterm births worldwide, prompting the need for reliable diagnostic tools. Advancements in testing technologies, such as point-of-care devices and non-invasive methods, enhance the efficiency and accuracy of early diagnosis, boosting market demand. Additionally, the awareness campaigns by health organizations are improving public understanding of preterm risks, encouraging timely testing, which is fueling the market growth. Furthermore, government initiatives and funding in maternal and child health further support market growth. Rising healthcare expenditure, especially in developing countries, enables better access to diagnostic services.

Top Companies Operated in Preterm Birth And PROM Testing Industry:

• Clinical Innovations LLC (Laborie Medical Technologies Inc.)
• Cooper Surgical Inc. (The Cooper Companies Inc.)
• Hologic Inc.
• IQ Products
• NX Prenatal Inc.
• Qiagen N.V
• Sera Prognostics

Key Highlights of the Report:

• Market Performance (2018–2023)
• Market Outlook (2024–2032)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1–631–791–1145